Benzinga's Top Upgrades

Loading...
Loading...

 

  • Baird upgraded Cintas Corporation CTAS from Neutral to Outperform. Cintas shares rose 2 percent to $115.25 in pre-market trading.
  • Analysts at Morgan Stanley upgraded Valeant Pharmaceuticals Intl Inc VRX from Equal-weight to Overweight. The price target for Valeant has been raised from $33 to $42. Valeant shares gained 9.85 percent to $29.22 in pre-market trading.
  • CL King upgraded Patrick Industries, Inc. PATK from Neutral to Buy. Patrick Industries shares gained 5.09 percent to $62.56 in pre-market trading.
  • Analysts at Wells Fargo upgraded AveXis Inc AVXS from Market Perform to Outperform. AveXis shares declined 4.38 percent to close at $41.66 on Tuesday.
  • PiperJaffray upgraded Markit Ltd INFO from Neutral to Overweight. IHS Markit shares slipped 0.17 percent to close at $35.26 on Tuesday.
  • Analysts at Deutsche Bank upgraded Brixmor Property Group Inc BRX from Hold to Buy. Brixmor Property shares declined 0.79 percent to close at $27.55 on Tuesday.
  • Analysts at Keefe Bruyette & Woods upgraded IBERIABANK Corp IBKC from Market Perform to Outperform. The price target for IBERIABANK has been raised from $67 to $72. IBERIABANK shares fell 0.05 percent to close at $64.69 on Tuesday.
  • Barclays upgraded Cintas Corporation CTAS from Equal-weight to Overweight. The price target for Cintas has been raised from $110 to $130. Cintas shares rose 2 percent to $115.25 in pre-market trading.
  • National Bank upgraded Stantec Inc. (USA) STN from Sector Perform to Outperform. Stantec shares rose 0.34 percent to close at $23.42 on Tuesday.
Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst Ratingstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...